HER2 Support Group Forums - View Single Post - Sphingotec reports new applications of bio-ADM at 39th ISICEM

News · 03-19-2019, 11:45 PM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

More...

03-19-2019, 11:45 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,955	Sphingotec reports new applications of bio-ADM at 39th ISICEM Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care. More...